Finance

Lists
600211:SHA
Tibet Rhodiola Pharmaceutical Holding Co
CN¥36,89
+0,49%
(+0,18) 1D
15 Okt., 10:52:25 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600211...
Open
CN¥36,52
High
CN¥37,09
Low
CN¥36,32
Mkt. cap
11,87 mjd
Avg. vol.
2,58 m
Volume
1,40 m
Dividend
5,48%
Quarterly dividend
CN¥0,51
Ex-dividend date
15 Sep. 2026
P/E ratio
12,05
52-wk high
CN¥49,85
52-wk low
CN¥34,80
EPS
CN¥3,06
Shares outstanding
179,62 m
No. of employees
671
Open
CN¥36,52
High
CN¥37,09
Low
CN¥36,32
Mkt. cap
11,87 mjd
Avg. vol.
2,58 m
Volume
1,40 m
Dividend
5,48%
Quarterly dividend
CN¥0,51
Ex-dividend date
15 Sep. 2026
P/E ratio
12,05
52-wk high
CN¥49,85
52-wk low
CN¥34,80
EPS
CN¥3,06
Shares outstanding
179,62 m
No. of employees
671
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
25 minute gelede
FILE PHOTO: SK Hynix at the Nasdaq market in New York
The Globe and Mail
The Globe and Mail
·
42 minute gelede
U.S. Analyst Updates: October 14th, 2026
Investor's Business Daily
Investor's Business Daily
·
38 minute gelede
Tech Futures Fall; Anthropic Revenue Jumps, But Not Enough?
About Tibet Rhodiola Pharmaceutical Holding Co
CEO-
Employees671
Founded14 Jul. 1999
Headquarters-
SectorHealth care provider
Websitexzyy.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
438,57 m
892,27 m
723,55 m
830,89 m
Cost of goods sold
41,19 m
41,01 m
51,38 m
61,25 m
Cost of revenue
41,19 m
41,01 m
51,38 m
61,25 m
Research and development expenses
9,35 m
45,96 m
26,48 m
31,41 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
248,18 m
569,90 m
425,75 m
483,46 m
Operating expense
218,72 m
669,38 m
457,07 m
529,78 m
Total operating expenses
259,91 m
710,39 m
508,44 m
591,03 m
Operating income
178,66 m
181,87 m
215,11 m
239,86 m
Other non operating income
1,73 m
-1,78 m
150,65 k
-229,61 k
EBT including unusual items
173,13 m
230,16 m
316,64 m
320,31 m
EBT excluding unusual items
191,14 m
188,37 m
224,35 m
244,42 m
Income tax expense
18,02 m
39,09 m
33,80 m
32,01 m
Effective tax rate
10,41%
16,98%
10,68%
9,99%
Other operating expenses
-38,78 m
54,69 m
4,84 m
15,06 m
Net income
154,45 m
216,15 m
298,71 m
309,25 m
Net profit margin
35,22%
24,23%
41,28%
37,22%
Earnings per share
-
-
-
-
Interest and investment income
14,86 m
17,37 m
19,24 m
18,48 m
Interest expense
-2,04 m
-10,40 m
-10,15 m
-12,18 m
Net interest expenses
12,82 m
6,97 m
9,09 m
6,30 m
Depreciation and amortization charges
-
-
-
-
EBITDA
197,21 m
201,24 m
234,47 m
262,41 m
Gain or loss from assets sale
152,70 k
-108,68 k
-
-
AI content may include mistakes. Learn more
Google-programme